Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
Public ClinicalTrials.gov record NCT01706432. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Biologic Endpoints in the Annihilation of Metastases for Oligometastasis (BEAM ON)
Study identification
- NCT ID
- NCT01706432
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- University of Chicago
- Other
- Enrollment
- 4 participants
Conditions and interventions
Conditions
- Central Nervous System Metastases
- Invasive Ductal Breast Carcinoma
- Invasive Ductal Breast Carcinoma With Predominant Intraductal Component
- Invasive Lobular Breast Carcinoma
- Invasive Lobular Breast Carcinoma With Predominant in Situ Component
- Liver Metastases
- Lobular Breast Carcinoma in Situ
- Lung Metastases
- Male Breast Cancer
- Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate
- Mucinous Ductal Breast Carcinoma
- Papillary Ductal Breast Carcinoma
- Recurrent Breast Cancer
- Stage IV Breast Cancer
- Tubular Ductal Breast Carcinoma
- Tumors Metastatic to Brain
Interventions
- hyperfractionated radiation therapy Radiation
- laboratory biomarker analysis Other
- stereotactic radiosurgery Radiation
Radiation · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 14, 2009
- Primary completion
- Jan 21, 2024
- Completion
- Jan 21, 2024
- Last update posted
- Jul 30, 2024
2009 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Chicago | North Chicago | Illinois | 60064 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01706432, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2024 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01706432 live on ClinicalTrials.gov.